Phillips-Van Heusen Corp (PVH) 108.56 $PVH Lululemon

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Phillips-Van Heusen Corp (PVH) 108.56 $PVH

Lululemon (LULU) Q2 Earnings & Sales In Line, View Strong
Zacks Equity Research - Zacks Investment Research - Fri Sep 02, 7:12AM CDT
Lululemon Athletica Inc. (LULU) reported second-quarter fiscal 2016 adjusted earnings of 38 cents per share, which came in line with the Zacks Consensus Estimate and leaped nearly 11.8% year over year.
DLA: 17.43 (-0.14), RL: 103.23 (-0.30), PVH: 108.56 (+0.38), LULU: 68.57 (-8.09)

Consumer Goods Stocks Under Scanner -- Ralph Lauren, PVH Corp., Callaway Golf, and Sportsman's Warehouse
PR Newswire - Fri Sep 02, 6:45AM CDT
Stock-Callers.com has its attention directed to the U.S. Consumer Goods space which was the largest sector in the world in 2015 and one of the best-performing sectors in the market at the start of this year. Under assessment today are these four familiar companies: Ralph Lauren Corp. (NYSE: RL), PVH Corp. (NYSE: PVH), Callaway Golf Co. (NYSE: ELY), and Sportsman's Warehouse Holdings Inc. (NASDAQ: SPWH). You can access of our complimentary research reports on these stocks now at:
ELY: 11.60 (+0.10), SPWH: 10.44 (-0.04), RL: 103.23 (-0.30), PVH: 108.56 (+0.38)

Buy Nike, Sell PVH? Forcerank’s Take on Apparel Retailers this Week
ESTMZ - Wed Aug 31, 11:54AM CDT
1. Nike ( NKE ): Nike shares were in a drought after dropping over 20% from their highs in June last year. However, strong technical indicators support the notion that the stock is recovering. The relative strength index recently crossed above its...
UA: 38.56 (-1.19), COH: 38.15 (-0.24), SPY: 218.37 (+0.98), NKE: 58.02 (-0.52), DECK: 63.20 (-0.82), VFC: 60.03 (-1.53), HBI: 26.40 (-0.12), RL: 103.23 (-0.30), PVH: 108.56 (+0.38), LULU: 68.57 (-8.09)

G-III Apparel (GIII) Lags Q2 Earnings, Trims View; Stock Falls
Zacks Equity Research - Zacks Investment Research - Wed Aug 31, 10:17AM CDT
Shares of, G-III Apparel Group, Ltd. (GIII) nosedived nearly 21% after the company reported dismal quarterly numbers for the second-quarter of fiscal 2017.
DLA: 17.43 (-0.14), GIII: 32.88 (+0.14), RL: 103.23 (-0.30), PVH: 108.56 (+0.38)

PVH Corp. Publishes 2015 Corporate Responsibility Report
BusinessWire - Mon Aug 29, 8:00AM CDT
PVH Corp. (NYSE VH) today released its eighth annual Corporate Responsibility (CR) report, which features an enhanced global CR strategy to address social and environmental issues that most affect PVH and provides an update on the progress on its 2015 initiatives. The report is available online at http://www.pvh.com/CR.
PVH: 108.56 (+0.38)

V.F. Corp (VFC) Refines Portfolio, Sells Contemporary Brands
Zacks Equity Research - Zacks Investment Research - Mon Aug 29, 6:21AM CDT
V.F. Corp. (VFC), on Friday, completed its previously announced sale of its underperforming Contemporary Brands business to Israel's Delta Galil Industries Ltd.
GES: 15.91 (-0.14), VFC: 60.03 (-1.53), RL: 103.23 (-0.30), PVH: 108.56 (+0.38)

4 Reasons Why You Should Buy Guess (GES) Now
Zacks Equity Research - Zacks Investment Research - Fri Aug 26, 2:38PM CDT
The apparel sector has been reporting declining comps and revenues because more and more buyers prefer to shop online.
GES: 15.91 (-0.14), DFBG: 4.80 (-0.17), RL: 103.23 (-0.30), PVH: 108.56 (+0.38)

Company News for August 26, 2016
Zacks Equity Research - Zacks Investment Research - Fri Aug 26, 8:56AM CDT
Companies In The News are: SIG,WDAY,TIF,PVH
WDAY: 88.98 (+1.09), TIF: 70.08 (-0.29), PVH: 108.56 (+0.38), SIG: 82.00 (+1.37)

Stock Market News for August 25, 2016
Zacks Equity Research - Zacks Investment Research - Thu Aug 25, 8:55AM CDT
Benchmarks ended in the red on Wednesday following decline in Mylan’s shares, which had a negative impact on the biotech stocks and eventually on the broader healthcare sector
FIT: 14.96 (+0.01), ENDP: 19.82 (-0.41), VRTX: 95.11 (+0.36), GILD: 76.89 (-0.53), CEO: 123.29 (+2.65), MYL: 39.97 (-1.95), ILMN: 167.90 (-0.66), SDRL: 2.42 (+0.09), HPQ: 14.49 (-0.01), PVH: 108.56 (+0.38)

PVH Corp. (PVH) Beats on Q2 Earnings, Raises EPS View
Zacks Equity Research - Zacks Investment Research - Thu Aug 25, 5:22AM CDT
PVH Corporation (PVH) delivered another strong quarter with second-quarter fiscal 2016 earnings per share surpassing estimates for the ninth consecutive quarter.
URBN: 36.10 (+0.32), DFBG: 4.80 (-0.17), RL: 103.23 (-0.30), PVH: 108.56 (+0.38)

PVH Corp. Reports 2016 Second Quarter EPS above Guidance and Raises Full Year EPS Guidance
BusinessWire - Wed Aug 24, 3:15PM CDT
--Second quarter EPS on a GAAP basis was $1.11 compared to $1.22 in the prior year period.
PVH: 108.56 (+0.38)

5 Stocks to Watch After the Market Closes Today
ESTMZ - Wed Aug 24, 8:00AM CDT
Hewlett-Packard ( HPQ ): Reduced YoY comparisons are a result of the spinout of HP and its enterprises segment. HP will continue to sell PCs and printers while HPE undertakes computer systems, software and tech services. HP has seen a steady decline...
GES: 15.91 (-0.14), SPY: 218.37 (+0.98), WDAY: 88.98 (+1.09), WSM: 52.03 (-0.07), HPQ: 14.49 (-0.01), PVH: 108.56 (+0.38)

4 Retail Stocks to Watch Tomorrow
ESTMZ - Tue Aug 23, 3:00PM CDT
Express ( EXPR ): Both earnings and revenue have trended down in recent quarters. Last quarter’s miss delivered -2% growth on the bottom line with a 32% decline on the top. This was supported by a 1% decline in ecommerce sales and 3% drop in...
GES: 15.91 (-0.14), SPY: 218.37 (+0.98), EXPR: 11.69 (-0.06), WSM: 52.03 (-0.07), PVH: 108.56 (+0.38)

Phillips-Van Heusen Set to Possibly Pullback After Yesterday's Rally of 1.58%
Comtex SmarTrend(R) - Tue Aug 23, 2:00PM CDT
Phillips-Van Heusen (NYSE VH) traded in a range yesterday that spanned from a low of $107.90 to a high of $110.72. Yesterday, the shares gained 1.6%, which took the trading range above the 3-day high of $108.27 on volume of 573,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
PVH: 108.56 (+0.38)

Look for Shares of Phillips-Van Heusen to Potentially Pullback after Yesterday's 1.58% Rise
Comtex SmarTrend(R) - Tue Aug 23, 1:58PM CDT
Phillips-Van Heusen (NYSE VH) traded in a range yesterday that spanned from a low of $107.90 to a high of $110.72. Yesterday, the shares gained 1.6%, which took the trading range above the 3-day high of $108.27 on volume of 573,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
PVH: 108.56 (+0.38)

PVH Corp. to Participate in the Goldman Sachs 23rd Annual Global Retailing Conference on September 7, 2016
BusinessWire - Fri Aug 19, 8:30AM CDT
PVH Corp. (NYSE: PVH) announced today that Company management will participate in the Goldman Sachs Twenty-Third Annual Global Retailing Conference on Wednesday, September 7, 2016. A live audio webcast of management's fireside chat will be broadcast online at 8:05 A.M. Eastern Daylight Time.
PVH: 108.56 (+0.38)

Can PVH Corp.'s (PVH) Q2 Earnings Maintain Solid Trend?
Zacks Equity Research - Zacks Investment Research - Wed Aug 17, 6:06AM CDT
PVH Corp. (PVH) is slated to release second-quarter fiscal 2016 results on Aug 24.
DLTR: 83.11 (-0.07), SAFM: 96.85 (+1.35), SBLK: 4.11 (+0.01), PVH: 108.56 (+0.38)

Phillips-Van Heusen Rises 4.46% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Thu Aug 11, 12:35PM CDT
Phillips-Van Heusen (NYSE VH) traded in a range yesterday that spanned from a low of $99.75 to a high of $103.90. Yesterday, the shares gained 4.5%, which took the trading range above the 3-day high of $100.38 on volume of 960,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
PVH: 108.56 (+0.38)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 7

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading
Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 4

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
Accuray, Samsung Push Boundaries with Imaging Deal

Updated Category News Views 4

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 3

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
Salveo Home Care Faces Class Action Over Labor Violations

Updated Category News Views 5

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Continue Reading
AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 4

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading
Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 6

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 4

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading

Top 5 Most Recently Viewed Articles

Vaccinex Unveils Efficacy Insights for Pepinemab in Alzheimer’s Study

Updated Category News Views 71

Vaccinex Provides Update on Pepinemab Study for Alzheimer’s Disease ROCHESTER, N.Y. — Vaccinex, Inc. (NASDAQ: VCNX), a forward-thinking biotechnology firm, is making significant strides in the treatment of Alzheimer's disease (AD) and cancer. The company is focused on a unique approach through the inhibition of Semaphorin 4D (SEMA4D). Recently, it was announced that...

Continue Reading
Legal Inquiry into Netflix, Inc. (NFLX) Attracts Investor Attention

Updated Category News Views 287

Understanding the Investigation into Netflix, Inc. Recently, the law firm Robbins Geller Rudman & Dowd LLP has initiated a formal investigation into Netflix, Inc. (NASDAQ: NFLX). This inquiry primarily focuses on potential violations of U.S. federal securities laws that may have occurred within the company. The Implications for Investors This investigation comes at a...

Continue Reading
Norway's Wealth Fund Expands Portfolio with London Investment

Updated Category News Views 221

Norway's Sovereign Wealth Fund Takes Bold Step in London Norway's sovereign wealth fund, expertly managed by Norges Bank Investment Management, has recently made headlines with its strategic acquisition of a 25% stake in a notable portfolio of office and retail properties located in London's prestigious Mayfair district. Significant Investment in a Prime Location This...

Continue Reading
Exagen Inc. Announces New Biomarkers and Financial Success

Updated Category News Views 291

Exagen Inc. Introduces Groundbreaking Biomarkers for Autoimmune Diseases Innovative testing aims to enhance patient diagnosis and care Exagen Inc. (Nasdaq: XGN), a pioneering company in autoimmune testing, has achieved a significant milestone by receiving conditional approval from the New York State Department of Health for its advanced assays to diagnose systemic lupus...

Continue Reading
Pacaso's Financial Growth in 2025: A Closer Look At Results

Updated Category News Views 1306

Pacaso Shows Promising First Half Financial Performance Pacaso, the innovative platform for co-owned luxury vacation homes, has recently shared its financial results for the first half of 2025, demonstrating strong stability and improved efficiency despite a challenging broader housing market. The company reported an impressive adjusted gross profit while managing to...

Continue Reading